Use of IVERMECTIN in Baguio as COVID-19 treatment thumbed down

December 7, 2021 Metro BLISTT

The Food and Drug Administration (FDA) and Baguio General Hospital and Medical Center (BGHMC) opposed the prospect of using an FDA approved antiparasitic drug called ivermectin as an oral treatment for COVID-19 patients in the city.
Councilor Benny Bomogao, in his resolution, invited representatives of the FDA and BGHMC to the city council’s regular session on November 29, 2021 to inquire whether the said drug can be prescribed to individuals infected with the virus.
Gomel Gabuna, Operating Officer of FDA North Luzon, strongly warned against the use of ivermectin to prevent or treat COVID-19 outside of a clinical trial.
Gabuna said the FDA prohibits the use of ivermectin as a cure for COVID-19 on the grounds that there is not enough scientific data to prove
the drug’s efficacy and safety when used for the said purpose.
“The FDA has approved the use of ivermectin but not for ingestion. It is only for topical purposes to treat parasites and skin diseases.
There are no standards yet prescribing how it will be used as an oral medicine by humans,” he stated.
The FDA official warned that there might be adverse effects of the said drug when its consumption is unsupervised.
He called on the medical practitioners prescribing ivermectin to COVID-19 patients to obtain a compassionate special permit (CSP) from the FDA.
A CSP is granted to physicians or hospitals for the use of investigational drugs that are not yet registered or in the process of registration here in the country for treating serious illnesses. The CSP holder must take full responsibility for the use of the requested drug product.
According to the FDA guidelines, the CSP does not assure the product’s safety, efficacy, and quality.
He also forewarned the city legislators of the legal implications of allowing the use of ivermectin as a COVID-19 treatment in the city without compelling medical practitioners or institutions who wish to prescribe or dispense ivermectin to obtain a CSP.
“If medical doctors are indiscriminately allowed by the city government to prescribe ivermectin, there is a possibility that any unscrupulous individual can easily claim that the death of a certain patient was caused by the use of ivermectin. The city government will open itself to lawsuits if it will allow the use of this untested drug,” the FDA official said.
He disclosed that, despite advisories issued and several operations conducted against the sale and distribution of ivermectin, the drug is still available in the market.
Meanwhile, Dr. Bernard Demot, an infectious disease specialist at the BGHMC, told the council that the Philippine Society for Microbiology and Infectious Diseases, along with other medical associations in the country, does not recommend the use of the anti-parasitic drug to cure and prevent COVID-19 due to lack of enough scientific evidence.
He, however, pointed out that a study on the efficacy of ivermectin as a COVID-19 cure are already being undertaken by the Department of Science and Technology (DOST) in the quarantine centers of Ateneo de Manila University, De La Salle University, University of the Philippines Diliman, and Makati Science High School.
According to him, it would be prudent for physicians to await the results of the said study.
The country should continue focusing on the proven and recommended measures against COVID-19, the infectious disease specialist further stressed.
“We have to intensify the vaccination roll-out, strengthen the public’s adherence to minimum health standards, and strengthen the healthcare capacity of the city, so that we can avoid severe cases in times of surges,” he underscored.
He also expressed that, as opposed to the use of dexamethasone, remdesivir, tocilizumab, and baricitinib which underwent rigorous scientific processes and were approved by medical associations, there is no substantial and compelling empirical evidence supporting the efficacy of ivermectin in treating and preventing COVID-19; thus, he cannot recommend it.
Dr. Samantha Bartolo, another infectious disease specialist at the BGHMC, cited the Ivermectin Treatment Efficacy in Covid-19 (ITEC) study recently done in Malaysia.
The study showed that there is no benefit in the use of ivermectin as a COVID-19 treatment and that it may cause diarrhea.
“As physicians, we follow the principle ‘Do not harm.’ Therefore, we will not advocate its use until there is further evidence,” Bartolo stated.
Jordan G. Habbiling/ABN